https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/aoci https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/dividends-preferred-stock https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/eps https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/inventory https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/line-of-credit-facility-increase-additional-borrowings https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/notes-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-deferred-costs-net https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-inventory-capitalized-costs https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/realized-gains-on-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/repayments-of-long-term-lines-of-credit https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/revenue-from-grants https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/share-price https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/straight-line-rent https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/kythera-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted